Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
KYLEENA Intrauterinsystem IUP 19.5 mg
Drug
Kyleena, Intrauterines Wirkstofffreisetzungssystem
Intrauterine Kontrazeption
09.02.2. – local contraceptives
HAM – Human medicine
IUWFS – Intrauterine delivery system
S – synthetic products for human use
B – Dispensed on prescription by a physician or veterinarian (B)
Z – approved
2/16/2017
12/31/9999
Dosage strength
Kyleena 19.5 mg, Intrauterines Wirkstofffreisetzungssystem
Intrauterine Kontrazeption
01
Z – approved
Package
7680661480019
In trade from / since 2/16/2017
A/R – Authorised / referenced
1 piece(s)
001
Z – approved
Declaration
Component
19.5 mg levonorgestrelum
poly(dimethylsiloxani) elastomerum
silica colloidalis anhydrica
polyethylenum
barii sulfas
polypropylenum
phthalocyaninum cupricum
argentum
silica colloidalis anhydrica
polyethylenum
barii sulfas
polypropylenum
phthalocyaninum cupricum
argentum
Authorisation holder
7601001002593
Bayer (Schweiz) AG
Grubenstrasse 8
8045 Zürich (ZH)
Grubenstrasse 8
8045 Zürich (ZH)
Date of revision of the text
12/1/2025
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.